Cargando…
Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts ≥500 Cells/µL) in the HIV Prevention Trials Network 071 (PopART) Trial in South Africa
BACKGROUND: There have been concerns about reduced adherence and human immunodeficiency virus (HIV) virological suppression (VS) among clinically well people initiating antiretroviral therapy (ART) with high pre-ART CD4 cell counts. We compared virological outcomes by pre-ART CD4 count, where univer...
Autores principales: | Fatti, Geoffrey, Grimwood, Ashraf, Nachega, Jean B, Nelson, Jenna A, LaSorda, Kelsea, van Zyl, Gert, Grobbelaar, Nelis, Ayles, Helen, Hayes, Richard, Beyers, Nulda, Fidler, Sarah, Bock, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768744/ https://www.ncbi.nlm.nih.gov/pubmed/30877753 http://dx.doi.org/10.1093/cid/ciz214 |
Ejemplares similares
-
Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa
por: Bock, Peter, et al.
Publicado: (2018) -
Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa
por: Bock, P, et al.
Publicado: (2019) -
Understanding low sensitivity of community-based HIV rapid testing: experiences from the HPTN 071 (PopART) trial in Zambia and South Africa
por: Bock, Peter, et al.
Publicado: (2017) -
Community‐ and individual‐level correlates of HIV incidence in HPTN 071 (PopART)
por: Skalland, Timothy, et al.
Publicado: (2023) -
What works – reaching universal HIV testing: lessons from HPTN 071 (PopART) trial in Zambia
por: Shanaube, Kwame, et al.
Publicado: (2017)